SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Drugs: From Discovery to Challenges in Clinical Use
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
Pharmacologic Measures of Adherence and Relationship to Drug Response
Peter L Anderson
University of Colorado, Denver, CO, United States
HIV-1 Combinectin BMS-986197: A Long-Acting Inhibitor With Multiple Modes of Action
Mark Krystal
Bristol-Myers Squibb, Wallingford, CT, United States
Long-Acting Oral and Parenteral Dosing of MK-8591 for HIV Treatment or Prophylaxis
Jay Grobler
Merck & Co, West Point, PA, United States
Lower Ribavirin Exposures in HIV+ Patients That Relapsed to Acute HCV Treatment
Christine E. MacBrayne
University of Colorado, Denver, CO, United States
Drug Interaction Studies Between Sofosbuvir/Velpatasvir and Boosted HIV ARV Regimens
Erik Mogalian
Gilead Sciences, Foster City, CA, United States
EFV Reduced PK of Piperaquine for Malaria Prevention in HIV+ Ugandan Pregnant Women
Richard Kajubi
Makerere University, Kampala, Uganda
Concentrations of TFV and TFVdp in Female Mucosal Tissues After a Single Dose of TAF
Katy L. Garrett
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
